Skip to main content

Table 4 Comparison of FEV1 between sensitised and non-sensitised patients with COPD 7.0–18.3% (weighted mean 13.6%

From: The global impact of Aspergillus infection on COPD

Author, year

FEV1 % of predicted

Number of patients

Sensitised

Non-sensitised

Jin et al, 2014 [25]

37

41

142

Everaerts et al, 2017 [26]

41

43

300

Agarwal et al, 2010 [27]

52.9

48.9

200

Bafadhel, 2014 [28]

39

51

128

Weighted average (weighted SD)

43.0 (7.0)

45.5 (4.6)